B Mark Evers

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 14

Top Venues

PloS one

Cancer research

Nature communications

Molecular cancer therapeutics

University of Kentucky

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Kentucky

United States

Director, Markey Cancer Center :: Surgery

Publications

Bo Dong, Xiang Song, Xinzhao Wang, Tao Dai, Jianlin Wang, Zhiyong Yu, Jiong Deng, B Mark Evers, Yadi Wu
FBXO24 suppresses breast cancer tumorigenesis by targeting LSD1 for Ubiquitination. Molecular cancer research : MCR (2023)
Lichao Guo, Wen Zhang, Yanqi Xie, Xi Chen, Emma E Olmstead, Mengqiang Lian, Baochen Zhang, Yekaterina Y Zaytseva, B Mark Evers, H Peter Spielmann, Xifu Liu, David S Watt, Chunming Liu
Diaminobutoxy-substituted Isoflavonoid (DBI-1) Enhances the Therapeutic Efficacy of GLUT1 Inhibitor BAY-876 by Modulating Metabolic Pathways in Colon Cancer Cells. Molecular cancer therapeutics 21 (5) (2022)
Zhuang-Zhuang Zhang, Lijun Cheng, Jie Li, Qi Qiao, Anju Karki, Derek B Allison, Nuha Shaker, Kunyu Li, Sagar M Utturkar, Nadia Atallah Lanman, Xiongjian Rao, Piotr Rychahou, Daheng He, Stephen F Konieczny, Chi Wang, Qing Shao, B Mark Evers, Xiaoqi Liu
Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy. Cancer research 82 (19) (2022)
Ruozheng Wei, Yuning Zhou, Chang Li, Piotr Rychahou, Shulin Zhang, William B Titlow, Greg Bauman, Yuanyuan Wu, Jinpeng Liu, Chi Wang, Heidi L Weiss, B Mark Evers, Qingding Wang
Ketogenesis Attenuates KLF5-Dependent Production of CXCL12 to Overcome the Immunosuppressive Tumor Microenvironment in Colorectal Cancer. Cancer research 82 (8) (2022)
Yanqi Xie, Wen Zhang, Lichao Guo, Liliia M Kril, Kristin L Begley, Vitaliy M Sviripa, Xi Chen, Xifu Liu, Eun Y Lee, Daheng He, Chi Wang, Tianyan Gao, Xiaoqi Liu, B Mark Evers, David S Watt, Chunming Liu
Potent Synergistic Effect on C-Myc-Driven Colorectal Cancers Using a Novel Indole-Substituted Quinoline with a Plk1 Inhibitor. Molecular cancer therapeutics 20 (10) (2021)
Yubin Guo, Qing Ye, Pan Deng, Yanan Cao, Daheng He, Zhaohe Zhou, Chi Wang, Yekaterina Y Zaytseva, Charles E Schwartz, Eun Y Lee, B Mark Evers, Andrew J Morris, Side Liu, Qing-Bai She
Spermine synthase and MYC cooperate to maintain colorectal cancer cell survival by repressing Bim expression. Nature communications 11 (1) (2020)
Jeremy Johnson, Zeta Chow, Dana Napier, Eun Lee, Heidi L Weiss, B Mark Evers, Piotr Rychahou
Targeting PI3K and AMPKα Signaling Alone or in Combination to Enhance Radiosensitivity of Triple Negative Breast Cancer. Cells 9 (5) (2020)
Tong Gan, Ashley T Stevens, Xiaopeng Xiong, Yang-An Wen, Trevor N Farmer, Austin T Li, Payton D Stevens, Sanam Golshani, Heidi L Weiss, B Mark Evers, Tianyan Gao
Inhibition of protein tyrosine phosphatase receptor type F suppresses Wnt signaling in colorectal cancer. Oncogene 39 (44) (2020)
Sijin Guo, Mario Vieweger, Kaiming Zhang, Hongran Yin, Hongzhi Wang, Xin Li, Shanshan Li, Shuiying Hu, Alex Sparreboom, B Mark Evers, Yizhou Dong, Wah Chiu, Peixuan Guo
Ultra-thermostable RNA nanoparticles for solubilizing and high-yield loading of paclitaxel for breast cancer therapy. Nature communications 11 (1) (2020)
Xiaopeng Xiong, Yang-An Wen, Rachelle Fairchild, Yekaterina Y Zaytseva, Heidi L Weiss, B Mark Evers, Tianyan Gao
Upregulation of CPT1A is essential for the tumor-promoting effect of adipocytes in colon cancer. Cell death & disease 11 (9) (2020)
Jeremy Johnson, Piotr Rychahou, Vitaliy M Sviripa, Heidi L Weiss, Chunming Liu, David S Watt, B Mark Evers
Induction of AMPK activation by N,N'-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers. PloS one 14 (3) (2019)
Stephanie Rock, Xian Li, Jun Song, Courtney M Townsend, Heidi L Weiss, Piotr Rychahou, Tianyan Gao, Jing Li, B Mark Evers
Kinase suppressor of Ras 1 and Exo70 promote fatty acid-stimulated neurotensin secretion through ERK1/2 signaling. PloS one 14 (3) (2019)
Heather F Sinner, Jeremy Johnson, Piotr G Rychahou, David S Watt, Yekaterina Y Zaytseva, Chunming Liu, B Mark Evers
Novel chemotherapeutic agent, FND-4b, activates AMPK and inhibits colorectal cancer cell proliferation. PloS one 14 (10) (2019)
Wen Zhang, Vitaliy M Sviripa, Liliia M Kril, Tianxin Yu, Yanqi Xie, William Brad Hubbard, Patrick G Sullivan, Xi Chen, Chang-Guo Zhan, Yang Yang-Hartwich, B Mark Evers, Brett T Spear, Roberto Gedaly, David S Watt, Chunming Liu
An Underlying Mechanism of Dual Wnt Inhibition and AMPK Activation: Mitochondrial Uncouplers Masquerading as Wnt Inhibitors. Journal of medicinal chemistry 62 (24) (2019)

B Mark Evers.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

B Mark Evers